3
Hindawi Publishing Corporation Case Reports in Cardiology Volume 2013, Article ID 754235, 2 pages http://dx.doi.org/10.1155/2013/754235 Case Report Giant Fibroelastoma of the Aortic Valve Michele di Summa and Federica Iezzi Division of Cardiac Surgery, Spitali Europian-GVM Care & Research, P.O. Box 1051, Autostrada Tiran¨ e-Durr¨ es, Qafa e Kasharit, tek Mbikalimi p¨ er Rinas, 1051 Tiran¨ e, Albania Correspondence should be addressed to Federica Iezzi; [email protected] Received 12 July 2013; Accepted 6 August 2013 Academic Editors: R. Akdemir and R. Bornemeier Copyright © 2013 M. di Summa and F. Iezzi. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Fibroelastomas account for less than 10% of all cardiac tumours, representing the most common valvular and the second most common cardiac benign tumour, following myxomas. Fibroelastomas are histologically benign; they can result in life-threatening complications such as stroke, acute valvular dysfunction, embolism, ventricular fibrillation, and sudden death. Surgical resection should be offered to all patients who have symptoms and to asymptomatic patients who have pedunculated lesions or tumors larger than 1 cm in diameter. Valve-sparing excision produces good long-term results in most instances. We report our surgical experience of a giant fibroelastoma in the aortic valve. 1. Introduction Cardiac fibroelastomas are the most common benign neo- plasms of the cardiac valvular structures. Fibroelastoma is oſten attached to valve leaflets, most oſten to the aortic valve, and less frequently to the tricus- pid, mitral, and pulmonary valves. Although most cases of fibroelastoma are incidental findings because they are asymp- tomatic, some show a strong propensity toward embolization, causing angina, myocardial infarction, transient ischemic attack, stroke, or sudden death when the tumor is in the leſt side of the heart. Here, we report our treatment of a giant aortic valve fi- broelastoma. 2. Case Report An 18-year-old man was referred for the evaluation of fatigue, chest pain, and syncope. His fatigue initially consisted of effort intolerance. He did not initially seek medical attention for his fatigue and syn- cope. His chest discomfort was described as a squeezing sen- sation that was substernal in location without radiation to any other position. His syncope was always preceded by subster- nal chest pressure, dizziness, and breathlessness. A transesophageal echocardiogram demonstrated a 70 mm mobile mass adherent to the leſt coronary cusp of the aortic valve, sign of leſt ventricular outflow tract obstruction. e mass was a pedunculated, echo dense, stipple in tex- ture structure, with well-demarcated borders, features typical of a fibroelastoma. e cardiac fibroelastoma was responsible for leſt ventric- ular outflow tract obstruction and valvular dysfunction. e patient underwent surgical excision of the mass. Preparation for operation, median sternotomy, cardio- pulmonary bypass, and myocardial management were per- formed. e tumor was found to have a wide attachment to the surface of the ventricular aspect of the leſt coronary cusp extending from the aortic annulus to the edge of the cusp. Tumor had well-demarcated borders and homogenous texture in appearance (Figure 1). e size of the tumor was about 70 mm × 20 mm (Figure 2). e tumor in the chamber had independent mobility on valvular endocardium surface and has an identifiable stalk. Aortic valve insufficiency was due to the delay of diagno- sis and following the mechanical trauma of the valve. A valve sparing technique with simple shave excision of the tumour was undertaken with particular care in avoiding

Case Report Giant Fibroelastoma of the Aortic Valvedownloads.hindawi.com/journals/cric/2013/754235.pdf · Case Report Giant Fibroelastoma of the Aortic Valve ... Spitali Europian

  • Upload
    lamnga

  • View
    216

  • Download
    2

Embed Size (px)

Citation preview

Page 1: Case Report Giant Fibroelastoma of the Aortic Valvedownloads.hindawi.com/journals/cric/2013/754235.pdf · Case Report Giant Fibroelastoma of the Aortic Valve ... Spitali Europian

Hindawi Publishing CorporationCase Reports in CardiologyVolume 2013, Article ID 754235, 2 pageshttp://dx.doi.org/10.1155/2013/754235

Case ReportGiant Fibroelastoma of the Aortic Valve

Michele di Summa and Federica Iezzi

Division of Cardiac Surgery, Spitali Europian−GVM Care & Research, P.O. Box 1051, Autostrada Tirane-Durres,Qafa e Kasharit, tek Mbikalimi per Rinas, 1051 Tirane, Albania

Correspondence should be addressed to Federica Iezzi; [email protected]

Received 12 July 2013; Accepted 6 August 2013

Academic Editors: R. Akdemir and R. Bornemeier

Copyright © 2013 M. di Summa and F. Iezzi. This is an open access article distributed under the Creative Commons AttributionLicense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properlycited.

Fibroelastomas account for less than 10% of all cardiac tumours, representing the most common valvular and the second mostcommon cardiac benign tumour, following myxomas. Fibroelastomas are histologically benign; they can result in life-threateningcomplications such as stroke, acute valvular dysfunction, embolism, ventricular fibrillation, and sudden death. Surgical resectionshould be offered to all patients who have symptoms and to asymptomatic patients who have pedunculated lesions or tumors largerthan 1 cm in diameter. Valve-sparing excision produces good long-term results inmost instances.We report our surgical experienceof a giant fibroelastoma in the aortic valve.

1. Introduction

Cardiac fibroelastomas are the most common benign neo-plasms of the cardiac valvular structures.

Fibroelastoma is often attached to valve leaflets, mostoften to the aortic valve, and less frequently to the tricus-pid, mitral, and pulmonary valves. Although most cases offibroelastoma are incidental findings because they are asymp-tomatic, some show a strong propensity toward embolization,causing angina, myocardial infarction, transient ischemicattack, stroke, or sudden death when the tumor is in the leftside of the heart.

Here, we report our treatment of a giant aortic valve fi-broelastoma.

2. Case Report

An 18-year-oldmanwas referred for the evaluation of fatigue,chest pain, and syncope.

His fatigue initially consisted of effort intolerance. He didnot initially seek medical attention for his fatigue and syn-cope. His chest discomfort was described as a squeezing sen-sation that was substernal in locationwithout radiation to anyother position. His syncope was always preceded by subster-nal chest pressure, dizziness, and breathlessness.

A transesophageal echocardiogram demonstrated a70mmmobile mass adherent to the left coronary cusp of theaortic valve, sign of left ventricular outflow tract obstruction.

The mass was a pedunculated, echo dense, stipple in tex-ture structure, with well-demarcated borders, features typicalof a fibroelastoma.

The cardiac fibroelastomawas responsible for left ventric-ular outflow tract obstruction and valvular dysfunction.

The patient underwent surgical excision of the mass.Preparation for operation, median sternotomy, cardio-

pulmonary bypass, and myocardial management were per-formed. The tumor was found to have a wide attachment tothe surface of the ventricular aspect of the left coronary cuspextending from the aortic annulus to the edge of the cusp.

Tumor had well-demarcated borders and homogenoustexture in appearance (Figure 1).

The size of the tumor was about 70mm × 20mm(Figure 2).

The tumor in the chamber had independent mobility onvalvular endocardium surface and has an identifiable stalk.

Aortic valve insufficiency was due to the delay of diagno-sis and following the mechanical trauma of the valve.

A valve sparing technique with simple shave excision ofthe tumour was undertaken with particular care in avoiding

Page 2: Case Report Giant Fibroelastoma of the Aortic Valvedownloads.hindawi.com/journals/cric/2013/754235.pdf · Case Report Giant Fibroelastoma of the Aortic Valve ... Spitali Europian

2 Case Reports in Cardiology

Figure 1: Giant aortic fibroelastoma.

Figure 2: Fibroelastoma after surgical excision.

embolization and ensuring that no remnants from fragmen-tation of the tumour were left behind both locally on the cuspand in the vicinity of ascending aorta and left ventricle.

Aortic valve competence was confirmed intraoperativelywith transesophageal echocardiographic approach before theaortotomy was closed.

Pathological examination of the excised mass showeda frond-like villous surface with a hyalinized myxoid core,delineated by a layer of endothelial cells—findings consistentwith a classic fibroelastoma.

The patient recovered without any complications andremained free of symptoms.

Nomass was detected by echocardiography in the patientduring the 6-month follow-up period.

3. Discussion

Cardiac fibroelastomas have a high propensity to affect theaortic valve, the left ventricular outflow tract, and the anteriormitral leaflet.

Fibroelastomas arising from semilunar valves are locatedwith equal frequencies on the ventricular and arterial sidesof the valves. In addition, nonvalvular origin was observedin approximately 16% cases that included left and right ven-tricular septal and mural endocardial surfaces, atrial endo-cardium, papillary muscles, chordae tendineae, or intima ofthe right coronary ostium [1].

The majority of patients are asymptomatic and thetumours are most often incidentally diagnosed. Fibroelas-tomas have the potential to lead to life-threatening compli-cations from embolization of fragments into the coronaryarteries, systemic circulation and pulmonary circulation, andleft ventricle outflow tract obstruction [2].

Symptomatic patients should be referred for curativesurgical excision of the tumour. Asymptomatic patients withlarge (>1 cm) mobile masses, especially left sided, should alsobe considered candidates for curative surgical excision dueto the increased risk of cardiovascular complications fromembolization and sudden cardiac death. Asymptomaticpatients with small left-sided nonmobile lesions are beingclosely followed up with echocardiography until symptomsdevelop or tumours enlarge and become mobile [3].

Aortic valve should be preserved preferably. In case thereis resultant valve defect, it should be repaired; otherwise avalve replacement is warranted.The surgical resection is cur-ative, safe, and well tolerated [4].

Conflict of Interests

The authors declare that there is no conflict of interests re-garding the publication of this paper.

References

[1] Y. Sato,H. Yokoyama,H. Satokawa, S. Takase, andY.Maruyama,“A report of a surgical case of papillary fibroelastoma in the leftventricular outflow tract,” Annals of Thoracic and Cardiovascu-lar Surgery, vol. 9, no. 4, pp. 270–273, 2003.

[2] R. R. Gopaldas, P. V. Atluri, A. S. Blaustein, F. G. Bakaeen, J.Huh, and D. Chu, “Papillary fibroelastoma of the aortic valve:operative approaches upon incidental discovery,” Texas HeartInstitute Journal, vol. 36, no. 2, pp. 160–163, 2009.

[3] D. L. Ngaage, C. J. Mullany, R. C. Daly et al., “Surgical treatmentof cardiac papillary fibroelastoma: a single center experiencewith eighty-eight patients,” Annals of Thoracic Surgery, vol. 80,no. 5, pp. 1712–1718, 2005.

[4] J.M.Grinda, J. P. Couetil, S. Chauvaud et al., “Cardiac valve pap-illary fibroelastoma: surgical excision for revealed or potentialembolization,” Journal of Thoracic and Cardiovascular Surgery,vol. 117, no. 1, pp. 106–110, 1999.

Page 3: Case Report Giant Fibroelastoma of the Aortic Valvedownloads.hindawi.com/journals/cric/2013/754235.pdf · Case Report Giant Fibroelastoma of the Aortic Valve ... Spitali Europian

Submit your manuscripts athttp://www.hindawi.com

Stem CellsInternational

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

MEDIATORSINFLAMMATION

of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Behavioural Neurology

EndocrinologyInternational Journal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Disease Markers

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

BioMed Research International

OncologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Oxidative Medicine and Cellular Longevity

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

PPAR Research

The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Journal of

ObesityJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Computational and Mathematical Methods in Medicine

OphthalmologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Diabetes ResearchJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Research and TreatmentAIDS

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Gastroenterology Research and Practice

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Parkinson’s Disease

Evidence-Based Complementary and Alternative Medicine

Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com